vs
C4 Therapeutics, Inc.（CCCC）与INTELLIGENT PROTECTION MANAGEMENT CORP.（IPM）财务数据对比。点击上方公司名可切换其他公司
C4 Therapeutics, Inc.的季度营收约是INTELLIGENT PROTECTION MANAGEMENT CORP.的1.8倍（$11.0M vs $6.1M），INTELLIGENT PROTECTION MANAGEMENT CORP.同比增速更快（2091.6% vs 112.8%），过去两年C4 Therapeutics, Inc.的营收复合增速更高（90.4% vs 54.7%）
C4 Therapeutics是一家临床阶段生物制药企业，专注于开发靶向蛋白降解疗法，用于治疗癌症及其他存在重大未满足医疗需求的严重疾病。公司依托自有专利TORPEDO平台设计小分子降解剂清除致病蛋白，目前拥有多条肿瘤领域研发管线，并与头部制药企业达成战略合作。
智能防护管理公司是一家总部位于英国格洛斯特郡的控股母公司，于2008年5月21日完成注册。公司为旗下四家子公司提供集团管理架构，其前身是专精于情报搜集、反间谍与反窃听检测业务的国际情报有限公司。
CCCC vs IPM — 直观对比
营收规模更大
CCCC
是对方的1.8倍
$6.1M
营收增速更快
IPM
高出1978.8%
112.8%
两年增速更快
CCCC
近两年复合增速
54.7%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $11.0M | $6.1M |
| 净利润 | $-20.5M | — |
| 毛利率 | — | 53.1% |
| 营业利润率 | -210.1% | -13.4% |
| 净利率 | -186.0% | — |
| 营收同比 | 112.8% | 2091.6% |
| 净利润同比 | 40.7% | — |
| 每股收益（稀释后） | $-0.09 | $-0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CCCCIPM
| Q4 25 | $11.0M | $6.1M | ||
| Q3 25 | $11.2M | $6.2M | ||
| Q2 25 | $6.5M | $5.7M | ||
| Q1 25 | $7.2M | $5.5M | ||
| Q4 24 | $5.2M | — | ||
| Q3 24 | $15.4M | — | ||
| Q2 24 | $12.0M | — | ||
| Q1 24 | $3.0M | — |
净利润CCCCIPM
| Q4 25 | $-20.5M | — | ||
| Q3 25 | $-32.2M | $-1.1M | ||
| Q2 25 | $-26.0M | $-1.1M | ||
| Q1 25 | $-26.3M | $808.5K | ||
| Q4 24 | $-34.6M | — | ||
| Q3 24 | $-24.7M | — | ||
| Q2 24 | $-17.7M | — | ||
| Q1 24 | $-28.4M | — |
毛利率CCCCIPM
| Q4 25 | — | 53.1% | ||
| Q3 25 | — | 50.7% | ||
| Q2 25 | — | 50.1% | ||
| Q1 25 | — | 55.3% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
营业利润率CCCCIPM
| Q4 25 | -210.1% | -13.4% | ||
| Q3 25 | -306.4% | -23.0% | ||
| Q2 25 | -441.0% | -19.7% | ||
| Q1 25 | -402.9% | -24.2% | ||
| Q4 24 | -728.4% | — | ||
| Q3 24 | -183.9% | — | ||
| Q2 24 | -178.6% | — | ||
| Q1 24 | -1060.2% | — |
净利率CCCCIPM
| Q4 25 | -186.0% | — | ||
| Q3 25 | -286.4% | -17.4% | ||
| Q2 25 | -402.6% | -18.3% | ||
| Q1 25 | -363.7% | 14.7% | ||
| Q4 24 | -667.8% | — | ||
| Q3 24 | -160.6% | — | ||
| Q2 24 | -147.6% | — | ||
| Q1 24 | -933.2% | — |
每股收益（稀释后）CCCCIPM
| Q4 25 | $-0.09 | $-0.05 | ||
| Q3 25 | $-0.44 | $-0.08 | ||
| Q2 25 | $-0.37 | $-0.08 | ||
| Q1 25 | $-0.37 | $0.06 | ||
| Q4 24 | $-0.50 | — | ||
| Q3 24 | $-0.35 | — | ||
| Q2 24 | $-0.26 | — | ||
| Q1 24 | $-0.41 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $74.6M | $5.6M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $256.6M | $18.2M |
| 总资产 | $359.1M | $26.0M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资CCCCIPM
| Q4 25 | $74.6M | $5.6M | ||
| Q3 25 | $58.8M | $7.3M | ||
| Q2 25 | $78.2M | $7.3M | ||
| Q1 25 | $51.3M | $9.7M | ||
| Q4 24 | $55.5M | — | ||
| Q3 24 | $59.6M | — | ||
| Q2 24 | $73.1M | — | ||
| Q1 24 | $89.7M | — |
股东权益CCCCIPM
| Q4 25 | $256.6M | $18.2M | ||
| Q3 25 | $154.4M | $18.8M | ||
| Q2 25 | $174.1M | $19.9M | ||
| Q1 25 | $195.1M | $21.1M | ||
| Q4 24 | $216.0M | — | ||
| Q3 24 | $242.7M | — | ||
| Q2 24 | $247.1M | — | ||
| Q1 24 | $258.3M | — |
总资产CCCCIPM
| Q4 25 | $359.1M | $26.0M | ||
| Q3 25 | $265.5M | $27.2M | ||
| Q2 25 | $296.5M | $29.8M | ||
| Q1 25 | $319.5M | $31.1M | ||
| Q4 24 | $349.6M | — | ||
| Q3 24 | $376.1M | — | ||
| Q2 24 | $381.1M | — | ||
| Q1 24 | $398.4M | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-22.1M | $87.6K |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流CCCCIPM
| Q4 25 | $-22.1M | $87.6K | ||
| Q3 25 | $-31.2M | $133.0K | ||
| Q2 25 | $-12.1M | $-888.7K | ||
| Q1 25 | $-33.3M | $1.7M | ||
| Q4 24 | $-17.9M | — | ||
| Q3 24 | $-24.1M | — | ||
| Q2 24 | $-5.0M | — | ||
| Q1 24 | $-18.1M | — |
自由现金流CCCCIPM
| Q4 25 | — | — | ||
| Q3 25 | $-31.6M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $-17.9M | — | ||
| Q3 24 | $-24.1M | — | ||
| Q2 24 | $-5.2M | — | ||
| Q1 24 | — | — |
自由现金流率CCCCIPM
| Q4 25 | — | — | ||
| Q3 25 | -281.5% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | -346.5% | — | ||
| Q3 24 | -157.2% | — | ||
| Q2 24 | -43.1% | — | ||
| Q1 24 | — | — |
资本支出强度CCCCIPM
| Q4 25 | — | — | ||
| Q3 25 | 3.7% | 0.0% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.1% | — | ||
| Q3 24 | 0.1% | — | ||
| Q2 24 | 1.6% | — | ||
| Q1 24 | 0.0% | — |
现金转化率CCCCIPM
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 2.16× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CCCC
暂无分部数据
IPM
| Procurement Revenue | $5.4M | 88% |
| Other | $743.9K | 12% |
